Pharmaceuticals, 2024 · DOI: https://doi.org/10.3390/ph17010071 · Published: January 4, 2024
This study explores the potential of using selenium and vitamin E to manage traumatic spinal cord injury (TSCI). These nutraceuticals have antioxidant properties and have shown promise in pre-clinical studies. The study also uses MRI tractography, a novel imaging method, to assess damage and potential recovery of nerve fibers in the spinal cord. The goal was to assess the feasibility of conducting a larger clinical trial, focusing on ease of enrollment, adherence to treatment, and participation in follow-up assessments.
The study demonstrates the feasibility of conducting larger, long-term clinical trials for TSCI treatment, which is crucial for further research in this area.
The combination of vitamin E and selenium shows promise as a safe treatment option for managing symptoms and potentially improving the condition of TSCI patients.
MRI tractography can be utilized as a valuable tool for assessing the extent of injury and monitoring the effects of treatment in TSCI, offering a non-invasive method for evaluating nerve fiber tracts.